| 0 |
HYPERMUTATION |
136 |
0.9714 |
| 1 |
MALIGNANT CRANIAL NERVE NEOPLASM |
17 |
0.6538 |
| 2 |
DESMOPLASTIC SMALL ROUND CELL TUMOUR |
47 |
0.5402 |
| 3 |
DNA MISMATCH REPAIR PROTEIN GENE MUTATION |
12 |
0.5000 |
| 4 |
ANAPLASTIC OLIGODENDROGLIOMA |
7 |
0.3684 |
| 5 |
RETRO-ORBITAL NEOPLASM |
17 |
0.3208 |
| 6 |
GLIOSARCOMA |
11 |
0.3143 |
| 7 |
BRAIN STEM GLIOMA |
35 |
0.2303 |
| 8 |
ANAPLASTIC ASTROCYTOMA |
35 |
0.2121 |
| 9 |
MEDULLOBLASTOMA RECURRENT |
23 |
0.2035 |
| 10 |
GLIOBLASTOMA MULTIFORME |
162 |
0.1924 |
| 11 |
NEUROBLASTOMA RECURRENT |
39 |
0.1921 |
| 12 |
ASTROCYTOMA |
74 |
0.1873 |
| 13 |
GLIOBLASTOMA |
312 |
0.1827 |
| 14 |
ALVEOLAR RHABDOMYOSARCOMA |
8 |
0.1818 |
| 15 |
TUMOUR PSEUDOPROGRESSION |
186 |
0.1699 |
| 16 |
MALIGNANT GLIOMA |
24 |
0.1690 |
| 17 |
GANGLIONEUROMA |
11 |
0.1667 |
| 18 |
AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT |
14 |
0.1573 |
| 19 |
OLIGODENDROGLIOMA |
17 |
0.1417 |
| 20 |
RADIATION NECROSIS |
67 |
0.1169 |
| 21 |
ASTROCYTOMA MALIGNANT |
12 |
0.1165 |
| 22 |
ANGINA BULLOSA HAEMORRHAGICA |
27 |
0.1164 |
| 23 |
PARATHYROID TUMOUR MALIGNANT |
14 |
0.1094 |
| 24 |
PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC |
24 |
0.1004 |
| 25 |
OPTIC GLIOMA |
9 |
0.0909 |
| 26 |
EPENDYMOMA |
13 |
0.0897 |
| 27 |
GLIOMA |
56 |
0.0871 |
| 28 |
BRAIN TUMOUR OPERATION |
17 |
0.0850 |
| 29 |
HERPES SIMPLEX ENCEPHALITIS |
38 |
0.0819 |
| 30 |
NEUROBLASTOMA |
31 |
0.0809 |
| 31 |
CORNEAL TOXICITY |
8 |
0.0721 |
| 32 |
HIPPOCAMPAL SCLEROSIS |
9 |
0.0703 |
| 33 |
BLOOD GASTRIN INCREASED |
9 |
0.0703 |
| 34 |
CENTRAL NERVOUS SYSTEM NECROSIS |
19 |
0.0691 |
| 35 |
VASOGENIC CEREBRAL OEDEMA |
49 |
0.0681 |
| 36 |
GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE |
7 |
0.0631 |
| 37 |
NEPHROBLASTOMA |
8 |
0.0630 |
| 38 |
MEDULLOBLASTOMA |
9 |
0.0604 |
| 39 |
ASTROCYTOMA, LOW GRADE |
10 |
0.0588 |
| 40 |
INTRACRANIAL TUMOUR HAEMORRHAGE |
22 |
0.0568 |
| 41 |
VANISHING BILE DUCT SYNDROME |
57 |
0.0511 |
| 42 |
ASPERGILLUS INFECTION |
327 |
0.0498 |
| 43 |
METASTASES TO SPINAL CORD |
9 |
0.0464 |
| 44 |
TUMOUR NECROSIS |
47 |
0.0445 |
| 45 |
PNEUMOCYSTIS JIROVECI INFECTION |
12 |
0.0433 |
| 46 |
VULVAL DISORDER |
27 |
0.0408 |
| 47 |
INSULINOMA |
7 |
0.0395 |
| 48 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED |
49 |
0.0393 |
| 49 |
RENAL-LIMITED THROMBOTIC MICROANGIOPATHY |
9 |
0.0391 |
| 50 |
CRANIOTOMY |
16 |
0.0390 |
| 51 |
PANCREATIC NEUROENDOCRINE TUMOUR |
25 |
0.0390 |
| 52 |
HAEMOGLOBIN |
7 |
0.0352 |
| 53 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
43 |
0.0312 |
| 54 |
CRYSTAL NEPHROPATHY |
18 |
0.0304 |
| 55 |
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL |
43 |
0.0296 |
| 56 |
FACIAL ASYMMETRY |
28 |
0.0294 |
| 57 |
MUSCLE SWELLING |
27 |
0.0293 |
| 58 |
CYTOPENIA |
356 |
0.0290 |
| 59 |
BONE MARROW TOXICITY |
33 |
0.0278 |
| 60 |
APLASTIC ANAEMIA |
144 |
0.0275 |
| 61 |
REFUSAL OF TREATMENT BY RELATIVE |
12 |
0.0265 |
| 62 |
LYMPHOPENIA |
367 |
0.0259 |
| 63 |
ENCEPHALOMALACIA |
14 |
0.0249 |
| 64 |
HAEMATOTOXICITY |
228 |
0.0240 |
| 65 |
DYSPHASIA |
11 |
0.0236 |
| 66 |
CHOLESTATIC LIVER INJURY |
51 |
0.0229 |
| 67 |
NEOPLASM RECURRENCE |
75 |
0.0221 |
| 68 |
METASTASES TO BONE MARROW |
11 |
0.0220 |
| 69 |
CANDIDA TEST POSITIVE |
9 |
0.0215 |
| 70 |
METASTASES TO PERITONEUM |
54 |
0.0214 |
| 71 |
ACQUIRED GENE MUTATION |
28 |
0.0214 |
| 72 |
RADIATION INJURY |
22 |
0.0207 |
| 73 |
BLOOD CHROMOGRANIN A INCREASED |
9 |
0.0196 |
| 74 |
DIABETES INSIPIDUS |
47 |
0.0195 |
| 75 |
RECURRENT CANCER |
79 |
0.0193 |
| 76 |
ENTEROCUTANEOUS FISTULA |
17 |
0.0193 |
| 77 |
PLATELET TRANSFUSION |
24 |
0.0186 |
| 78 |
DISSEMINATED CRYPTOCOCCOSIS |
14 |
0.0185 |
| 79 |
INTRACRANIAL HYPOTENSION |
12 |
0.0184 |
| 80 |
NEUROENDOCRINE TUMOUR |
26 |
0.0183 |
| 81 |
METASTASES TO MENINGES |
41 |
0.0180 |
| 82 |
BRAIN NEOPLASM MALIGNANT |
80 |
0.0179 |
| 83 |
HOSPICE CARE |
176 |
0.0178 |
| 84 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
39 |
0.0175 |
| 85 |
CENTRAL NERVOUS SYSTEM HAEMORRHAGE |
8 |
0.0172 |
| 86 |
METASTATIC MALIGNANT MELANOMA |
39 |
0.0170 |
| 87 |
TUMOUR HAEMORRHAGE |
48 |
0.0168 |
| 88 |
NEPHROGENIC DIABETES INSIPIDUS |
19 |
0.0165 |
| 89 |
GLIOSIS |
7 |
0.0163 |
| 90 |
HYDROCEPHALUS |
88 |
0.0161 |
| 91 |
BRAIN SCAN ABNORMAL |
9 |
0.0161 |
| 92 |
DISEASE PROGRESSION |
1895 |
0.0160 |
| 93 |
BRAIN OEDEMA |
199 |
0.0157 |
| 94 |
BONE MARROW DEPRESSION |
15 |
0.0154 |
| 95 |
IIIRD NERVE PARALYSIS |
12 |
0.0148 |
| 96 |
SIALOADENITIS |
20 |
0.0147 |
| 97 |
CEREBRAL ASPERGILLOSIS |
9 |
0.0146 |
| 98 |
EARLY SATIETY |
28 |
0.0144 |
| 99 |
THROMBOCYTOPENIA |
1592 |
0.0142 |
| 100 |
ENCEPHALITIS HERPES |
7 |
0.0142 |
| 101 |
THERAPY PARTIAL RESPONDER |
220 |
0.0141 |
| 102 |
BONE MARROW FAILURE |
284 |
0.0140 |
| 103 |
METASTASES TO LIVER |
242 |
0.0138 |
| 104 |
JAW OPERATION |
12 |
0.0135 |
| 105 |
LOBAR PNEUMONIA |
25 |
0.0135 |
| 106 |
ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC |
10 |
0.0133 |
| 107 |
FAT NECROSIS |
8 |
0.0132 |
| 108 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
29 |
0.0131 |
| 109 |
NEOPLASM PROGRESSION |
454 |
0.0130 |
| 110 |
BRAIN CANCER METASTATIC |
9 |
0.0130 |
| 111 |
METAPNEUMOVIRUS INFECTION |
10 |
0.0128 |
| 112 |
FEBRILE NEUTROPENIA |
839 |
0.0126 |
| 113 |
INTUSSUSCEPTION |
12 |
0.0126 |
| 114 |
ORAL INTAKE REDUCED |
30 |
0.0124 |
| 115 |
SIMPLE PARTIAL SEIZURES |
10 |
0.0124 |
| 116 |
NEUTROPHIL COUNT ABNORMAL |
35 |
0.0124 |
| 117 |
BRAIN OPERATION |
28 |
0.0123 |
| 118 |
GENE MUTATION |
24 |
0.0121 |
| 119 |
METASTASES TO SPINE |
40 |
0.0119 |
| 120 |
NEUROLOGICAL DECOMPENSATION |
27 |
0.0117 |
| 121 |
DRUG CLEARANCE DECREASED |
15 |
0.0115 |
| 122 |
MONOCYTE COUNT DECREASED |
14 |
0.0115 |
| 123 |
TRANSFUSION REACTION |
10 |
0.0114 |
| 124 |
BRAIN NEOPLASM |
104 |
0.0113 |
| 125 |
TUMOUR EXCISION |
9 |
0.0112 |
| 126 |
NONINFECTIVE ENCEPHALITIS |
8 |
0.0111 |
| 127 |
METASTASES TO LYMPH NODES |
74 |
0.0110 |
| 128 |
B-CELL TYPE ACUTE LEUKAEMIA |
8 |
0.0109 |
| 129 |
CREPITATIONS |
31 |
0.0104 |
| 130 |
HEMIPARESIS |
174 |
0.0103 |
| 131 |
CEREBRAL CYST |
7 |
0.0102 |
| 132 |
UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE |
11 |
0.0100 |
| 133 |
PERIPHERAL MOTOR NEUROPATHY |
14 |
0.0100 |
| 134 |
PELVIC MASS |
8 |
0.0099 |
| 135 |
LIVER ABSCESS |
32 |
0.0099 |
| 136 |
CEREBROSPINAL FLUID LEAKAGE |
18 |
0.0097 |
| 137 |
CENTRAL NERVOUS SYSTEM INFECTION |
11 |
0.0096 |
| 138 |
INTRACRANIAL MASS |
9 |
0.0095 |
| 139 |
WHITE MATTER LESION |
12 |
0.0095 |
| 140 |
SKIN STRIAE |
14 |
0.0094 |
| 141 |
METASTASIS |
67 |
0.0094 |
| 142 |
HEPATIC CANCER METASTATIC |
8 |
0.0093 |
| 143 |
MYELOSUPPRESSION |
336 |
0.0093 |
| 144 |
STRONGYLOIDIASIS |
15 |
0.0093 |
| 145 |
THROMBOPHLEBITIS SUPERFICIAL |
28 |
0.0092 |
| 146 |
MYELITIS TRANSVERSE |
13 |
0.0092 |
| 147 |
MALIGNANT NEOPLASM PROGRESSION |
944 |
0.0092 |
| 148 |
CRYPTOCOCCOSIS |
15 |
0.0092 |
| 149 |
PARTIAL SEIZURES |
48 |
0.0092 |
| 150 |
PANCYTOPENIA |
510 |
0.0091 |
| 151 |
METASTASES TO LUNG |
105 |
0.0091 |
| 152 |
MENINGITIS BACTERIAL |
13 |
0.0091 |
| 153 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
117 |
0.0091 |
| 154 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
55 |
0.0090 |
| 155 |
COMPLEX PARTIAL SEIZURES |
10 |
0.0090 |
| 156 |
PARAPARESIS |
16 |
0.0090 |
| 157 |
OPTIC NEUROPATHY |
19 |
0.0090 |
| 158 |
CD4 LYMPHOCYTES DECREASED |
19 |
0.0089 |
| 159 |
CEREBRAL VENTRICLE DILATATION |
10 |
0.0087 |
| 160 |
POSTOPERATIVE WOUND COMPLICATION |
11 |
0.0086 |
| 161 |
RADIATION SKIN INJURY |
10 |
0.0086 |
| 162 |
BILIARY OBSTRUCTION |
11 |
0.0085 |
| 163 |
PNEUMONIA CRYPTOCOCCAL |
8 |
0.0085 |
| 164 |
CAMPYLOBACTER INFECTION |
7 |
0.0084 |
| 165 |
ASPERGILLOSIS |
11 |
0.0084 |
| 166 |
NEUROLOGICAL SYMPTOM |
48 |
0.0084 |
| 167 |
LYMPHOCYTE COUNT DECREASED |
147 |
0.0083 |
| 168 |
ARRHYTHMIA SUPRAVENTRICULAR |
9 |
0.0082 |
| 169 |
OPPORTUNISTIC INFECTION |
15 |
0.0081 |
| 170 |
HEMIANOPIA |
8 |
0.0081 |
| 171 |
BLOOD ALKALINE PHOSPHATASE ABNORMAL |
7 |
0.0078 |
| 172 |
POSTICTAL STATE |
8 |
0.0077 |
| 173 |
NEUTROPENIA |
1041 |
0.0076 |
| 174 |
RENAL INFARCT |
11 |
0.0076 |
| 175 |
HEPATIC LESION |
32 |
0.0074 |
| 176 |
DIVERTICULAR PERFORATION |
15 |
0.0073 |
| 177 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
72 |
0.0072 |
| 178 |
COAGULATION TIME PROLONGED |
11 |
0.0071 |
| 179 |
VITH NERVE PARALYSIS |
8 |
0.0070 |
| 180 |
HEPATITIS B REACTIVATION |
22 |
0.0069 |
| 181 |
MENTAL STATUS CHANGES |
191 |
0.0069 |
| 182 |
TONGUE ULCERATION |
23 |
0.0068 |
| 183 |
PACKED RED BLOOD CELL TRANSFUSION |
9 |
0.0068 |
| 184 |
DISEASE RECURRENCE |
321 |
0.0067 |
| 185 |
CANDIDIASIS |
27 |
0.0067 |
| 186 |
PNEUMONIA CYTOMEGALOVIRAL |
13 |
0.0067 |
| 187 |
NOCARDIOSIS |
17 |
0.0066 |
| 188 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
10 |
0.0066 |
| 189 |
BLOOD PRESSURE DIASTOLIC INCREASED |
30 |
0.0065 |
| 190 |
MYELODYSPLASTIC SYNDROME |
94 |
0.0065 |
| 191 |
FACIAL PALSY |
14 |
0.0065 |
| 192 |
GASTROINTESTINAL TOXICITY |
31 |
0.0064 |
| 193 |
MULTIPLE-DRUG RESISTANCE |
20 |
0.0064 |
| 194 |
IMMUNE THROMBOCYTOPENIC PURPURA |
18 |
0.0064 |
| 195 |
FAILURE TO THRIVE |
33 |
0.0063 |
| 196 |
SPLENIC INFARCTION |
11 |
0.0063 |
| 197 |
MENINGITIS CRYPTOCOCCAL |
11 |
0.0063 |
| 198 |
LEUKOPENIA |
314 |
0.0063 |
| 199 |
BLOOD BILIRUBIN ABNORMAL |
8 |
0.0062 |
| 200 |
EXPOSURE VIA FATHER |
8 |
0.0061 |
| 201 |
LUNG CONSOLIDATION |
17 |
0.0061 |
| 202 |
BRAIN HERNIATION |
18 |
0.0060 |
| 203 |
BLOOD CULTURE POSITIVE |
18 |
0.0060 |
| 204 |
DRUG RESISTANCE |
154 |
0.0060 |
| 205 |
SYSTEMIC CANDIDA |
15 |
0.0060 |
| 206 |
ACUTE MYELOID LEUKAEMIA |
93 |
0.0060 |
| 207 |
OTOTOXICITY |
11 |
0.0059 |
| 208 |
PRODUCT USE IN UNAPPROVED INDICATION |
1474 |
0.0059 |
| 209 |
INTRACRANIAL PRESSURE INCREASED |
33 |
0.0059 |
| 210 |
PARAINFLUENZAE VIRUS INFECTION |
9 |
0.0059 |
| 211 |
HAEMOGLOBIN ABNORMAL |
38 |
0.0059 |
| 212 |
PLATELET COUNT DECREASED |
625 |
0.0059 |
| 213 |
CLOSTRIDIUM COLITIS |
7 |
0.0058 |
| 214 |
ENCEPHALITIS VIRAL |
7 |
0.0057 |
| 215 |
HYPOPITUITARISM |
10 |
0.0057 |
| 216 |
SINUS ARREST |
9 |
0.0057 |
| 217 |
IDIOPATHIC THROMBOCYTOPENIC PURPURA |
9 |
0.0057 |
| 218 |
DRUG TOLERANCE DECREASED |
16 |
0.0057 |
| 219 |
LICHENOID KERATOSIS |
13 |
0.0057 |
| 220 |
CONVULSION |
324 |
0.0057 |
| 221 |
ATAXIA |
67 |
0.0056 |
| 222 |
WHITE BLOOD CELL COUNT ABNORMAL |
36 |
0.0056 |
| 223 |
WOUND DEHISCENCE |
19 |
0.0056 |
| 224 |
HYPERNATRAEMIA |
28 |
0.0056 |
| 225 |
EMBOLISM VENOUS |
17 |
0.0056 |
| 226 |
OESOPHAGITIS |
61 |
0.0056 |
| 227 |
PROTEIN TOTAL DECREASED |
21 |
0.0056 |
| 228 |
PNEUMONIA FUNGAL |
22 |
0.0056 |
| 229 |
PNEUMONIA STAPHYLOCOCCAL |
11 |
0.0056 |
| 230 |
METASTATIC NEOPLASM |
24 |
0.0056 |
| 231 |
OPTIC ATROPHY |
9 |
0.0055 |
| 232 |
ARTERIOSPASM CORONARY |
22 |
0.0055 |
| 233 |
EMBOLISM |
45 |
0.0054 |
| 234 |
LARGE INTESTINE PERFORATION |
37 |
0.0053 |
| 235 |
GASTROINTESTINAL PERFORATION |
22 |
0.0053 |
| 236 |
ATELECTASIS |
51 |
0.0053 |
| 237 |
METASTASES TO BONE |
86 |
0.0052 |
| 238 |
DIFFICULTY IN WALKING |
18 |
0.0052 |
| 239 |
INFREQUENT BOWEL MOVEMENTS |
13 |
0.0052 |
| 240 |
CYTOMEGALOVIRUS COLITIS |
12 |
0.0052 |
| 241 |
PETECHIAE |
54 |
0.0052 |
| 242 |
HAEMORRHAGE INTRACRANIAL |
77 |
0.0051 |
| 243 |
LANGUAGE DISORDER |
11 |
0.0051 |
| 244 |
FUNGAEMIA |
8 |
0.0051 |
| 245 |
RALES |
29 |
0.0050 |
| 246 |
CUSHINGOID |
16 |
0.0050 |
| 247 |
CRANIOCEREBRAL INJURY |
15 |
0.0050 |
| 248 |
MUCOSAL INFLAMMATION |
128 |
0.0049 |
| 249 |
HYPERTRANSAMINASAEMIA |
34 |
0.0049 |
| 250 |
LUNG INFILTRATION |
43 |
0.0049 |
| 251 |
APHASIA |
147 |
0.0049 |
| 252 |
WHITE BLOOD CELL DISORDER |
13 |
0.0049 |
| 253 |
LEUKOENCEPHALOPATHY |
18 |
0.0048 |
| 254 |
HYPOPROTEINAEMIA |
9 |
0.0047 |
| 255 |
BRAIN ABSCESS |
12 |
0.0047 |
| 256 |
NEUTROPHIL COUNT DECREASED |
193 |
0.0047 |
| 257 |
DIFFUSE LARGE B-CELL LYMPHOMA |
36 |
0.0047 |
| 258 |
NECROSIS |
26 |
0.0047 |
| 259 |
MENINGITIS |
31 |
0.0046 |
| 260 |
BODY TEMPERATURE DECREASED |
45 |
0.0046 |
| 261 |
PSEUDOMONAL SEPSIS |
8 |
0.0046 |
| 262 |
HYPOPHOSPHATAEMIA |
33 |
0.0045 |
| 263 |
PULMONARY EMBOLISM |
423 |
0.0044 |
| 264 |
GRAND MAL CONVULSION |
41 |
0.0044 |
| 265 |
COMPUTERISED TOMOGRAM ABNORMAL |
10 |
0.0044 |
| 266 |
HYPOALBUMINAEMIA |
34 |
0.0044 |
| 267 |
NEUTROPENIC SEPSIS |
31 |
0.0043 |
| 268 |
PERFORMANCE STATUS DECREASED |
20 |
0.0043 |
| 269 |
HYPERGLYCAEMIA |
156 |
0.0043 |
| 270 |
VITILIGO |
10 |
0.0043 |
| 271 |
BRONCHOPULMONARY ASPERGILLOSIS |
33 |
0.0043 |
| 272 |
FEBRILE BONE MARROW APLASIA |
18 |
0.0042 |
| 273 |
DEEP VEIN THROMBOSIS |
275 |
0.0042 |
| 274 |
ANTIBODY TEST POSITIVE |
7 |
0.0042 |
| 275 |
PNEUMATOSIS INTESTINALIS |
12 |
0.0042 |
| 276 |
NEOPLASM |
48 |
0.0042 |
| 277 |
SEIZURE |
472 |
0.0041 |
| 278 |
BLOOD CHLORIDE INCREASED |
7 |
0.0040 |
| 279 |
ANAEMIA |
765 |
0.0040 |
| 280 |
RASH MORBILLIFORM |
11 |
0.0040 |
| 281 |
DEAFNESS NEUROSENSORY |
13 |
0.0039 |
| 282 |
INFECTION |
570 |
0.0039 |
| 283 |
DISEASE COMPLICATION |
18 |
0.0039 |
| 284 |
CANCER PAIN |
10 |
0.0039 |
| 285 |
SMALL INTESTINAL OBSTRUCTION |
48 |
0.0039 |
| 286 |
METHAEMOGLOBINAEMIA |
9 |
0.0039 |
| 287 |
ATRIAL FIBRILLATION |
376 |
0.0039 |
| 288 |
HAEMORRHAGE |
401 |
0.0038 |
| 289 |
BLOOD CALCIUM DECREASED |
43 |
0.0038 |
| 290 |
PULMONARY INFARCTION |
9 |
0.0038 |
| 291 |
ACUTE HEPATIC FAILURE |
52 |
0.0038 |
| 292 |
PLATELET COUNT ABNORMAL |
23 |
0.0038 |
| 293 |
ALANINE AMINOTRANSFERASE ABNORMAL |
8 |
0.0038 |
| 294 |
ASCITES |
111 |
0.0038 |
| 295 |
WOUND INFECTION |
41 |
0.0037 |
| 296 |
PROTEINURIA |
71 |
0.0037 |
| 297 |
HEMIPLEGIA |
31 |
0.0037 |
| 298 |
BLOOD SODIUM INCREASED |
10 |
0.0037 |
| 299 |
VENOOCCLUSIVE LIVER DISEASE |
18 |
0.0036 |
| 300 |
HEPATIC MASS |
7 |
0.0036 |
| 301 |
EMERGENCY CARE |
11 |
0.0036 |
| 302 |
IMMUNOSUPPRESSION |
32 |
0.0036 |
| 303 |
MALNUTRITION |
40 |
0.0036 |
| 304 |
VENOUS THROMBOSIS |
14 |
0.0036 |
| 305 |
CLOSTRIDIAL INFECTION |
12 |
0.0035 |
| 306 |
DISTRIBUTIVE SHOCK |
8 |
0.0035 |
| 307 |
OESOPHAGEAL CANDIDIASIS |
14 |
0.0035 |
| 308 |
NEUROTOXICITY |
61 |
0.0035 |
| 309 |
ALANINE AMINOTRANSFERASE INCREASED |
213 |
0.0035 |
| 310 |
HYPOKALAEMIA |
160 |
0.0035 |
| 311 |
ENTEROCOLITIS |
20 |
0.0035 |
| 312 |
ADRENAL INSUFFICIENCY |
42 |
0.0035 |
| 313 |
HEPATOTOXICITY |
77 |
0.0035 |
| 314 |
THERAPY CHANGE |
34 |
0.0035 |
| 315 |
ORGANISING PNEUMONIA |
17 |
0.0034 |
| 316 |
PNEUMONITIS |
93 |
0.0034 |
| 317 |
BLOOD ALBUMIN DECREASED |
27 |
0.0034 |
| 318 |
FLUID INTAKE REDUCED |
17 |
0.0034 |
| 319 |
FACIAL PARESIS |
12 |
0.0034 |
| 320 |
CAPILLARY LEAK SYNDROME |
7 |
0.0034 |
| 321 |
INTESTINAL PERFORATION |
38 |
0.0034 |
| 322 |
AKINESIA |
7 |
0.0034 |
| 323 |
DEVICE RELATED INFECTION |
52 |
0.0034 |
| 324 |
BLOOD MAGNESIUM DECREASED |
29 |
0.0034 |
| 325 |
ECCHYMOSIS |
23 |
0.0034 |
| 326 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
59 |
0.0033 |
| 327 |
NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL |
11 |
0.0033 |
| 328 |
NO THERAPEUTIC RESPONSE |
40 |
0.0033 |
| 329 |
ANOREXIA |
42 |
0.0033 |
| 330 |
DRUG TOXICITY |
44 |
0.0032 |
| 331 |
SEPSIS |
360 |
0.0032 |
| 332 |
HEPATIC CYTOLYSIS |
41 |
0.0032 |
| 333 |
CEREBRAL HAEMORRHAGE |
115 |
0.0032 |
| 334 |
PLATELET DISORDER |
8 |
0.0032 |
| 335 |
FACIAL PARALYSIS |
27 |
0.0032 |
| 336 |
ERYTHEMA MULTIFORME |
29 |
0.0031 |
| 337 |
WHITE BLOOD CELL COUNT DECREASED |
337 |
0.0031 |
| 338 |
BLOOD CHLORIDE DECREASED |
8 |
0.0031 |
| 339 |
SUSPECTED OFF LABEL USE |
14 |
0.0031 |
| 340 |
SPINAL CORD COMPRESSION |
12 |
0.0031 |
| 341 |
BLOOD BILIRUBIN INCREASED |
83 |
0.0031 |
| 342 |
NEPHROTIC SYNDROME |
21 |
0.0031 |
| 343 |
STATUS EPILEPTICUS |
34 |
0.0030 |
| 344 |
SKIN TOXICITY |
17 |
0.0030 |
| 345 |
METABOLIC ENCEPHALOPATHY |
9 |
0.0030 |
| 346 |
HYPERBILIRUBINAEMIA |
31 |
0.0030 |
| 347 |
MIXED LIVER INJURY |
9 |
0.0030 |
| 348 |
HEPATITIS B |
18 |
0.0030 |
| 349 |
ABDOMINAL MASS |
8 |
0.0030 |
| 350 |
PULMONARY TOXICITY |
21 |
0.0030 |
| 351 |
ORAL CANDIDIASIS |
39 |
0.0030 |
| 352 |
HYPONATRAEMIA |
166 |
0.0029 |
| 353 |
EOSINOPHIL COUNT DECREASED |
7 |
0.0029 |
| 354 |
NEPHROPATHY TOXIC |
33 |
0.0029 |
| 355 |
TYPE IV HYPERSENSITIVITY REACTION |
8 |
0.0029 |
| 356 |
REFUSAL OF TREATMENT BY PATIENT |
19 |
0.0029 |
| 357 |
AGRANULOCYTOSIS |
54 |
0.0029 |
| 358 |
CHOLECYSTITIS INFECTIVE |
8 |
0.0029 |
| 359 |
SEPTIC SHOCK |
125 |
0.0029 |
| 360 |
ASPARTATE AMINOTRANSFERASE INCREASED |
152 |
0.0029 |
| 361 |
COGNITIVE DISORDER |
133 |
0.0028 |
| 362 |
CLOSTRIDIUM DIFFICILE INFECTION |
62 |
0.0028 |
| 363 |
CLOSTRIDIUM DIFFICILE COLITIS |
30 |
0.0028 |
| 364 |
HAEMATOCRIT DECREASED |
56 |
0.0028 |
| 365 |
ESCHERICHIA URINARY TRACT INFECTION |
12 |
0.0028 |
| 366 |
INTRAVENTRICULAR HAEMORRHAGE |
7 |
0.0028 |
| 367 |
ENTERITIS |
18 |
0.0028 |
| 368 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
65 |
0.0028 |
| 369 |
INCOHERENT |
18 |
0.0028 |
| 370 |
BACTERAEMIA |
33 |
0.0028 |
| 371 |
MYOPATHY |
24 |
0.0028 |
| 372 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
44 |
0.0028 |
| 373 |
PARAPLEGIA |
8 |
0.0028 |
| 374 |
FINE MOTOR SKILL DYSFUNCTION |
8 |
0.0028 |
| 375 |
BACTERIAL SEPSIS |
9 |
0.0028 |
| 376 |
DYSLIPIDAEMIA |
14 |
0.0028 |
| 377 |
CACHEXIA |
14 |
0.0027 |
| 378 |
EPILEPSY |
83 |
0.0027 |
| 379 |
MALIGNANT MELANOMA |
36 |
0.0027 |
| 380 |
POTENTIATING DRUG INTERACTION |
9 |
0.0027 |
| 381 |
PROTHROMBIN TIME PROLONGED |
16 |
0.0027 |
| 382 |
HEPATITIS CHOLESTATIC |
16 |
0.0027 |
| 383 |
HEPATIC NECROSIS |
10 |
0.0027 |
| 384 |
PULSELESS ELECTRICAL ACTIVITY |
11 |
0.0026 |
| 385 |
BREAST PAIN |
28 |
0.0026 |
| 386 |
DEHYDRATION |
350 |
0.0026 |
| 387 |
AREFLEXIA |
7 |
0.0026 |
| 388 |
HAEMORRHOIDS |
51 |
0.0026 |
| 389 |
PNEUMONIA ASPIRATION |
65 |
0.0026 |
| 390 |
NERVE COMPRESSION |
24 |
0.0026 |
| 391 |
HYPERTRIGLYCERIDAEMIA |
15 |
0.0026 |
| 392 |
ESCHERICHIA INFECTION |
21 |
0.0026 |
| 393 |
ELECTROENCEPHALOGRAM ABNORMAL |
8 |
0.0025 |
| 394 |
TRANSAMINASES INCREASED |
56 |
0.0025 |
| 395 |
COORDINATION ABNORMAL |
35 |
0.0025 |
| 396 |
ILEUS |
31 |
0.0025 |
| 397 |
VENTRICULAR HYPOKINESIA |
8 |
0.0025 |
| 398 |
ABDOMINAL ABSCESS |
11 |
0.0025 |
| 399 |
MONOCYTE COUNT INCREASED |
9 |
0.0025 |
| 400 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
63 |
0.0024 |
| 401 |
ENCEPHALOPATHY |
60 |
0.0024 |
| 402 |
HYPOGAMMAGLOBULINAEMIA |
16 |
0.0024 |
| 403 |
ESCHERICHIA SEPSIS |
7 |
0.0024 |
| 404 |
DRUG-INDUCED LIVER INJURY |
75 |
0.0024 |
| 405 |
BLOOD COUNT ABNORMAL |
36 |
0.0024 |
| 406 |
BLOOD DISORDER |
19 |
0.0024 |
| 407 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
12 |
0.0024 |
| 408 |
MASS |
33 |
0.0024 |
| 409 |
B-CELL LYMPHOMA |
8 |
0.0024 |
| 410 |
PALLOR |
64 |
0.0023 |
| 411 |
LUNG NEOPLASM |
10 |
0.0023 |
| 412 |
CONFUSIONAL STATE |
378 |
0.0023 |
| 413 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
58 |
0.0023 |
| 414 |
CEREBRAL ISCHAEMIA |
12 |
0.0023 |
| 415 |
HEPATIC FIBROSIS |
8 |
0.0023 |
| 416 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
22 |
0.0023 |
| 417 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
51 |
0.0023 |
| 418 |
DERMATITIS ACNEIFORM |
14 |
0.0023 |
| 419 |
CHOLECYSTITIS ACUTE |
13 |
0.0023 |
| 420 |
CHEST X-RAY ABNORMAL |
7 |
0.0023 |
| 421 |
HYPOXIA |
80 |
0.0023 |
| 422 |
SUBARACHNOID HAEMORRHAGE |
23 |
0.0023 |
| 423 |
LETHARGY |
129 |
0.0022 |
| 424 |
TUBULOINTERSTITIAL NEPHRITIS |
42 |
0.0022 |
| 425 |
METABOLIC DISORDER |
13 |
0.0022 |
| 426 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
16 |
0.0022 |
| 427 |
STAPHYLOCOCCAL SEPSIS |
11 |
0.0022 |
| 428 |
COLITIS |
84 |
0.0022 |
| 429 |
THERAPY CESSATION |
113 |
0.0022 |
| 430 |
GENERALISED TONIC-CLONIC SEIZURE |
36 |
0.0022 |
| 431 |
TOXIC EPIDERMAL NECROLYSIS |
33 |
0.0022 |
| 432 |
ENCEPHALITIS |
15 |
0.0022 |
| 433 |
URINARY INCONTINENCE |
64 |
0.0022 |
| 434 |
CONSTIPATION |
471 |
0.0022 |
| 435 |
HYPOPHAGIA |
55 |
0.0021 |
| 436 |
HEPATIC NEOPLASM |
7 |
0.0021 |
| 437 |
HEPATIC ENCEPHALOPATHY |
20 |
0.0021 |
| 438 |
RESPIRATORY RATE INCREASED |
19 |
0.0021 |
| 439 |
HEPATOMEGALY |
21 |
0.0021 |
| 440 |
HAEMOLYTIC ANAEMIA |
19 |
0.0021 |
| 441 |
HEPATIC PAIN |
9 |
0.0021 |
| 442 |
VOMITING |
991 |
0.0021 |
| 443 |
CYTOMEGALOVIRUS INFECTION |
35 |
0.0021 |
| 444 |
DEATH |
1811 |
0.0021 |
| 445 |
OFF LABEL USE |
1833 |
0.0021 |
| 446 |
HAEMOGLOBIN DECREASED |
213 |
0.0021 |
| 447 |
POISONING |
26 |
0.0021 |
| 448 |
THERAPY NON-RESPONDER |
93 |
0.0021 |
| 449 |
HYPOCALCAEMIA |
39 |
0.0021 |
| 450 |
DISORIENTATION |
81 |
0.0020 |
| 451 |
DRUG ERUPTION |
36 |
0.0020 |
| 452 |
CHOLELITHIASIS |
66 |
0.0020 |
| 453 |
MENINGITIS ASEPTIC |
9 |
0.0020 |
| 454 |
LOGORRHOEA |
7 |
0.0020 |
| 455 |
CYSTITIS HAEMORRHAGIC |
8 |
0.0020 |
| 456 |
ELECTROLYTE IMBALANCE |
23 |
0.0020 |
| 457 |
CHOLESTASIS |
38 |
0.0020 |
| 458 |
FIBRIN D DIMER INCREASED |
7 |
0.0020 |
| 459 |
DECUBITUS ULCER |
16 |
0.0020 |
| 460 |
REBOUND EFFECT |
22 |
0.0019 |
| 461 |
HYPERURICAEMIA |
8 |
0.0019 |
| 462 |
LEUKOCYTOSIS |
35 |
0.0019 |
| 463 |
ACUTE RESPIRATORY FAILURE |
37 |
0.0019 |
| 464 |
RESPIRATORY DISTRESS |
53 |
0.0019 |
| 465 |
RESPIRATORY FAILURE |
140 |
0.0019 |
| 466 |
RENAL FAILURE ACUTE |
81 |
0.0019 |
| 467 |
CARDIOTOXICITY |
17 |
0.0019 |
| 468 |
HEPATIC FUNCTION ABNORMAL |
71 |
0.0019 |
| 469 |
INCONTINENCE |
20 |
0.0019 |
| 470 |
SUBDURAL HAEMATOMA |
27 |
0.0019 |
| 471 |
AORTIC VALVE INCOMPETENCE |
8 |
0.0019 |
| 472 |
MUSCULOSKELETAL CHEST PAIN |
29 |
0.0019 |
| 473 |
OSTEONECROSIS OF JAW |
46 |
0.0019 |
| 474 |
CHEMOTHERAPY |
7 |
0.0018 |
| 475 |
DISSEMINATED INTRAVASCULAR COAGULATION |
26 |
0.0018 |
| 476 |
FAECES DISCOLOURED |
40 |
0.0018 |
| 477 |
FACE INJURY |
7 |
0.0018 |
| 478 |
DYSARTHRIA |
69 |
0.0018 |
| 479 |
URINE OUTPUT DECREASED |
16 |
0.0018 |
| 480 |
OEDEMA |
99 |
0.0018 |
| 481 |
PYREXIA |
628 |
0.0018 |
| 482 |
DRUG LEVEL INCREASED |
30 |
0.0018 |
| 483 |
VISUAL FIELD DEFECT |
13 |
0.0018 |
| 484 |
CARDIOPULMONARY FAILURE |
7 |
0.0018 |
| 485 |
MOTOR DYSFUNCTION |
18 |
0.0018 |
| 486 |
BLOOD PRESSURE DIASTOLIC DECREASED |
13 |
0.0018 |
| 487 |
PLEURAL EFFUSION |
107 |
0.0018 |
| 488 |
CEREBRAL ATROPHY |
7 |
0.0018 |
| 489 |
GRANULOCYTOPENIA |
10 |
0.0018 |
| 490 |
VISUAL DISTURBANCE |
10 |
0.0017 |
| 491 |
ASTHENIA |
649 |
0.0017 |
| 492 |
HYPOMAGNESAEMIA |
24 |
0.0017 |
| 493 |
RED BLOOD CELL COUNT DECREASED |
49 |
0.0017 |
| 494 |
PERIPHERAL SENSORY NEUROPATHY |
10 |
0.0017 |
| 495 |
DEMYELINATION |
7 |
0.0017 |
| 496 |
ABASIA |
42 |
0.0017 |
| 497 |
PROCEDURAL COMPLICATION |
13 |
0.0017 |
| 498 |
PHARYNGOLARYNGEAL PAIN |
9 |
0.0017 |
| 499 |
BLOOD PRESSURE SYSTOLIC INCREASED |
33 |
0.0017 |
| 500 |
HEPATIC FAILURE |
51 |
0.0017 |
| 501 |
MUSCULAR WEAKNESS |
192 |
0.0017 |
| 502 |
NAUSEA |
1332 |
0.0017 |
| 503 |
SPEECH DISORDER |
88 |
0.0017 |
| 504 |
GENERAL PHYSICAL HEALTH DETERIORATION |
194 |
0.0017 |
| 505 |
BLOOD UREA INCREASED |
28 |
0.0017 |
| 506 |
EPISTAXIS |
124 |
0.0017 |
| 507 |
PULMONARY THROMBOSIS |
18 |
0.0016 |
| 508 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
65 |
0.0016 |
| 509 |
THROMBOTIC MICROANGIOPATHY |
16 |
0.0016 |
| 510 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
90 |
0.0016 |
| 511 |
PNEUMOTHORAX |
26 |
0.0016 |
| 512 |
TRICUSPID VALVE INCOMPETENCE |
13 |
0.0016 |
| 513 |
TACHYPNOEA |
22 |
0.0016 |
| 514 |
ABDOMINAL TENDERNESS |
8 |
0.0016 |
| 515 |
HYDRONEPHROSIS |
12 |
0.0016 |
| 516 |
NERVOUS SYSTEM DISORDER |
50 |
0.0016 |
| 517 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
12 |
0.0016 |
| 518 |
FULL BLOOD COUNT DECREASED |
32 |
0.0016 |
| 519 |
POLYURIA |
13 |
0.0016 |
| 520 |
DYSPHAGIA |
150 |
0.0016 |
| 521 |
CYTOMEGALOVIRUS VIRAEMIA |
7 |
0.0016 |
| 522 |
LIPASE INCREASED |
12 |
0.0016 |
| 523 |
FEMORAL NECK FRACTURE |
8 |
0.0016 |
| 524 |
ANAL INCONTINENCE |
14 |
0.0016 |
| 525 |
HYPERCHOLESTEROLAEMIA |
15 |
0.0016 |
| 526 |
ASPIRATION |
17 |
0.0016 |
| 527 |
SKIN WARM |
9 |
0.0015 |
| 528 |
TOXICITY TO VARIOUS AGENTS |
260 |
0.0015 |
| 529 |
HERPES SIMPLEX |
10 |
0.0015 |
| 530 |
HYPOVOLAEMIA |
9 |
0.0015 |
| 531 |
CENTRAL NERVOUS SYSTEM LESION |
21 |
0.0015 |
| 532 |
RASH MACULO-PAPULAR |
34 |
0.0015 |
| 533 |
BUNDLE BRANCH BLOCK RIGHT |
7 |
0.0015 |
| 534 |
BLOOD LACTIC ACID INCREASED |
8 |
0.0015 |
| 535 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
43 |
0.0015 |
| 536 |
LOCALISED OEDEMA |
7 |
0.0015 |
| 537 |
NYSTAGMUS |
8 |
0.0015 |
| 538 |
SQUAMOUS CELL CARCINOMA |
14 |
0.0015 |
| 539 |
CEREBRAL DISORDER |
11 |
0.0015 |
| 540 |
BLOOD SODIUM DECREASED |
28 |
0.0015 |
| 541 |
FOETAL GROWTH RESTRICTION |
9 |
0.0015 |
| 542 |
DIVERTICULITIS |
41 |
0.0015 |
| 543 |
THROMBOSIS |
119 |
0.0015 |
| 544 |
SINUS TACHYCARDIA |
21 |
0.0015 |
| 545 |
BODY TEMPERATURE INCREASED |
30 |
0.0015 |
| 546 |
GINGIVAL BLEEDING |
20 |
0.0015 |
| 547 |
MOVEMENT DISORDER |
47 |
0.0015 |
| 548 |
HYPOVOLAEMIC SHOCK |
7 |
0.0015 |
| 549 |
DECREASED APPETITE |
338 |
0.0015 |
| 550 |
OLIGURIA |
9 |
0.0014 |
| 551 |
JAUNDICE |
39 |
0.0014 |
| 552 |
HERPES ZOSTER |
83 |
0.0014 |
| 553 |
HAEMODYNAMIC INSTABILITY |
11 |
0.0014 |
| 554 |
SARS-COV-2 TEST POSITIVE |
19 |
0.0014 |
| 555 |
STREPTOCOCCAL INFECTION |
8 |
0.0014 |
| 556 |
TRANSFUSION |
15 |
0.0014 |
| 557 |
PULMONARY ALVEOLAR HAEMORRHAGE |
8 |
0.0014 |
| 558 |
PNEUMONIA BACTERIAL |
13 |
0.0014 |
| 559 |
LUNG INFECTION |
22 |
0.0014 |
| 560 |
HEPATITIS |
36 |
0.0014 |
| 561 |
C-REACTIVE PROTEIN INCREASED |
51 |
0.0014 |
| 562 |
BRAIN INJURY |
14 |
0.0014 |
| 563 |
UNRESPONSIVE TO STIMULI |
36 |
0.0014 |
| 564 |
STEVENS-JOHNSON SYNDROME |
31 |
0.0014 |
| 565 |
BLOOD URIC ACID INCREASED |
8 |
0.0014 |
| 566 |
LIVER INJURY |
34 |
0.0014 |
| 567 |
ALTERED STATE OF CONSCIOUSNESS |
30 |
0.0014 |
| 568 |
DYSPHORIA |
7 |
0.0014 |
| 569 |
ABSCESS |
22 |
0.0014 |
| 570 |
NEUTROPHIL COUNT INCREASED |
14 |
0.0014 |
| 571 |
GROIN PAIN |
12 |
0.0014 |
| 572 |
BLOOD POTASSIUM DECREASED |
41 |
0.0014 |
| 573 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
14 |
0.0014 |
| 574 |
INTENTIONAL PRODUCT USE ISSUE |
119 |
0.0014 |
| 575 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
8 |
0.0013 |
| 576 |
DRUG EFFECT INCOMPLETE |
49 |
0.0013 |
| 577 |
FATIGUE |
1050 |
0.0013 |
| 578 |
DIPLOPIA |
35 |
0.0013 |
| 579 |
PNEUMONIA |
436 |
0.0013 |
| 580 |
LIVER FUNCTION TEST ABNORMAL |
39 |
0.0013 |
| 581 |
TREATMENT FAILURE |
111 |
0.0013 |
| 582 |
GENERAL PHYSICAL CONDITION ABNORMAL |
9 |
0.0013 |
| 583 |
ACUTE KIDNEY INJURY |
202 |
0.0013 |
| 584 |
STOMATITIS |
80 |
0.0013 |
| 585 |
RASH GENERALISED |
34 |
0.0013 |
| 586 |
HOSPITALISATION |
201 |
0.0013 |
| 587 |
DROOLING |
9 |
0.0013 |
| 588 |
POST PROCEDURAL COMPLICATION |
25 |
0.0013 |
| 589 |
PERSONALITY CHANGE |
12 |
0.0013 |
| 590 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
10 |
0.0013 |
| 591 |
TACHYCARDIA |
114 |
0.0013 |
| 592 |
PSEUDOMONAS INFECTION |
11 |
0.0013 |
| 593 |
EPSTEIN-BARR VIRUS INFECTION |
8 |
0.0013 |
| 594 |
PULMONARY HAEMORRHAGE |
10 |
0.0013 |
| 595 |
WHITE BLOOD CELL COUNT INCREASED |
49 |
0.0013 |
| 596 |
MANIA |
21 |
0.0013 |
| 597 |
MULTI-ORGAN FAILURE |
22 |
0.0013 |
| 598 |
NIGHT SWEATS |
41 |
0.0013 |
| 599 |
LEUKAEMIA |
12 |
0.0013 |
| 600 |
INTESTINAL ISCHAEMIA |
7 |
0.0013 |
| 601 |
CHILLS |
149 |
0.0013 |
| 602 |
NEEDLE ISSUE |
37 |
0.0013 |
| 603 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
25 |
0.0013 |
| 604 |
ABDOMINAL PAIN |
293 |
0.0013 |
| 605 |
FREQUENT BOWEL MOVEMENTS |
34 |
0.0013 |
| 606 |
PRODUCT USE ISSUE |
236 |
0.0013 |
| 607 |
PROCTALGIA |
8 |
0.0012 |
| 608 |
NEOPLASM MALIGNANT |
83 |
0.0012 |
| 609 |
SENSORY LOSS |
10 |
0.0012 |
| 610 |
DIARRHOEA |
801 |
0.0012 |
| 611 |
BACTERIAL INFECTION |
23 |
0.0012 |
| 612 |
HEAD INJURY |
39 |
0.0012 |
| 613 |
FULL BLOOD COUNT ABNORMAL |
13 |
0.0012 |
| 614 |
DEAFNESS |
32 |
0.0012 |
| 615 |
LIVER DISORDER |
54 |
0.0012 |
| 616 |
THERAPY INTERRUPTED |
87 |
0.0012 |
| 617 |
MEDICAL DEVICE COMPLICATION |
9 |
0.0012 |
| 618 |
GASTROINTESTINAL DISORDER |
109 |
0.0012 |
| 619 |
GENERALISED OEDEMA |
15 |
0.0012 |
| 620 |
CELLULITIS |
61 |
0.0012 |
| 621 |
PULMONARY MASS |
18 |
0.0012 |
| 622 |
SECOND PRIMARY MALIGNANCY |
10 |
0.0012 |
| 623 |
PANCREATITIS ACUTE |
27 |
0.0012 |
| 624 |
SKIN ULCER |
31 |
0.0012 |
| 625 |
PRODUCTIVE COUGH |
57 |
0.0012 |
| 626 |
UROSEPSIS |
11 |
0.0012 |
| 627 |
IMPAIRED HEALING |
39 |
0.0012 |
| 628 |
POSTOPERATIVE WOUND INFECTION |
8 |
0.0012 |
| 629 |
CANDIDA INFECTION |
20 |
0.0012 |
| 630 |
HYPERTHERMIA |
9 |
0.0012 |
| 631 |
URINARY RETENTION |
39 |
0.0012 |
| 632 |
ADVERSE EVENT |
107 |
0.0012 |
| 633 |
URINARY TRACT INFECTION |
196 |
0.0011 |
| 634 |
SUPRAVENTRICULAR TACHYCARDIA |
11 |
0.0011 |
| 635 |
HYPOTENSION |
230 |
0.0011 |
| 636 |
DERMATITIS |
24 |
0.0011 |
| 637 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
81 |
0.0011 |
| 638 |
FEEDING DISORDER |
23 |
0.0011 |
| 639 |
HYPERCALCAEMIA |
14 |
0.0011 |
| 640 |
PURPURA |
10 |
0.0011 |
| 641 |
CHOLANGITIS |
7 |
0.0011 |
| 642 |
PHARYNGITIS |
14 |
0.0011 |
| 643 |
MUSCLE TWITCHING |
26 |
0.0011 |
| 644 |
WEIGHT DECREASED |
314 |
0.0011 |
| 645 |
ISCHAEMIC STROKE |
20 |
0.0011 |
| 646 |
HAEMATOMA |
29 |
0.0011 |
| 647 |
HYPERTENSION |
237 |
0.0011 |
| 648 |
PARALYSIS |
16 |
0.0011 |
| 649 |
POST PROCEDURAL HAEMORRHAGE |
13 |
0.0011 |
| 650 |
DRUG INTERACTION |
175 |
0.0011 |
| 651 |
OEDEMA PERIPHERAL |
134 |
0.0011 |
| 652 |
STAPHYLOCOCCAL INFECTION |
36 |
0.0011 |
| 653 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
9 |
0.0011 |
| 654 |
UPPER RESPIRATORY TRACT INFECTION |
50 |
0.0011 |
| 655 |
ANGINA UNSTABLE |
7 |
0.0011 |
| 656 |
BRADYPHRENIA |
7 |
0.0011 |
| 657 |
APPENDICITIS |
10 |
0.0011 |
| 658 |
FALL |
355 |
0.0011 |
| 659 |
HEPATOCELLULAR INJURY |
15 |
0.0011 |
| 660 |
HYPOGLYCAEMIA |
51 |
0.0011 |
| 661 |
GAIT DISTURBANCE |
201 |
0.0010 |
| 662 |
DRUG INTOLERANCE |
101 |
0.0010 |
| 663 |
FEAR |
28 |
0.0010 |
| 664 |
SUDDEN DEATH |
11 |
0.0010 |
| 665 |
PERICARDIAL EFFUSION |
24 |
0.0010 |
| 666 |
EATING DISORDER |
22 |
0.0010 |
| 667 |
APNOEA |
8 |
0.0010 |
| 668 |
ABNORMAL LOSS OF WEIGHT |
7 |
0.0010 |
| 669 |
LIVER FUNCTION TEST INCREASED |
22 |
0.0010 |
| 670 |
CEREBRAL INFARCTION |
25 |
0.0010 |
| 671 |
RENAL TUBULAR NECROSIS |
10 |
0.0010 |
| 672 |
BLOOD CREATININE INCREASED |
66 |
0.0010 |
| 673 |
RENAL CYST |
8 |
0.0010 |
| 674 |
ATRIAL FLUTTER |
8 |
0.0010 |
| 675 |
OSTEOMYELITIS |
18 |
0.0010 |
| 676 |
CONTUSION |
95 |
0.0010 |
| 677 |
BLOOD POTASSIUM INCREASED |
16 |
0.0010 |
| 678 |
DRUG LEVEL DECREASED |
10 |
0.0010 |
| 679 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
9 |
0.0010 |
| 680 |
ORTHOSTATIC HYPOTENSION |
17 |
0.0010 |
| 681 |
HYPOTHYROIDISM |
31 |
0.0010 |
| 682 |
TEMPERATURE INTOLERANCE |
10 |
0.0010 |
| 683 |
DRUG INEFFECTIVE |
1270 |
0.0010 |
| 684 |
BALANCE DISORDER |
83 |
0.0010 |
| 685 |
FLANK PAIN |
9 |
0.0010 |
| 686 |
EOSINOPHIL COUNT INCREASED |
8 |
0.0010 |
| 687 |
GASTROENTERITIS |
14 |
0.0010 |
| 688 |
NEUROPATHY PERIPHERAL |
91 |
0.0010 |
| 689 |
HYPERSOMNIA |
27 |
0.0009 |
| 690 |
TASTE DISORDER |
19 |
0.0009 |
| 691 |
GASTROINTESTINAL HAEMORRHAGE |
78 |
0.0009 |
| 692 |
SOMNOLENCE |
187 |
0.0009 |
| 693 |
HEPATIC ENZYME INCREASED |
63 |
0.0009 |
| 694 |
DIABETES MELLITUS |
70 |
0.0009 |
| 695 |
BLOOD PRESSURE DECREASED |
61 |
0.0009 |
| 696 |
COELIAC DISEASE |
9 |
0.0009 |
| 697 |
ACIDOSIS |
7 |
0.0009 |
| 698 |
OSTEONECROSIS |
30 |
0.0009 |
| 699 |
BEDRIDDEN |
12 |
0.0009 |
| 700 |
INTERNATIONAL NORMALISED RATIO INCREASED |
26 |
0.0009 |
| 701 |
PHOTOPHOBIA |
17 |
0.0009 |
| 702 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
26 |
0.0009 |
| 703 |
INTESTINAL OBSTRUCTION |
34 |
0.0009 |
| 704 |
HYPOTONIA |
9 |
0.0009 |
| 705 |
FLATULENCE |
51 |
0.0009 |
| 706 |
TOXIC SKIN ERUPTION |
9 |
0.0009 |
| 707 |
DELIRIUM |
31 |
0.0009 |
| 708 |
SKIN INFECTION |
10 |
0.0009 |
| 709 |
DYSSTASIA |
26 |
0.0009 |
| 710 |
HEADACHE |
557 |
0.0009 |
| 711 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
26 |
0.0009 |
| 712 |
CYST |
11 |
0.0009 |
| 713 |
FURUNCLE |
7 |
0.0009 |
| 714 |
RASH PRURITIC |
47 |
0.0009 |
| 715 |
NEURALGIA |
21 |
0.0009 |
| 716 |
HEPATIC STEATOSIS |
16 |
0.0009 |
| 717 |
OXYGEN SATURATION DECREASED |
48 |
0.0009 |
| 718 |
HAEMATURIA |
29 |
0.0008 |
| 719 |
DIALYSIS |
12 |
0.0008 |
| 720 |
AMNESIA |
55 |
0.0008 |
| 721 |
ILL-DEFINED DISORDER |
51 |
0.0008 |
| 722 |
IMMUNE SYSTEM DISORDER |
11 |
0.0008 |
| 723 |
PANCREATITIS |
44 |
0.0008 |
| 724 |
SYNCOPE |
83 |
0.0008 |
| 725 |
PRODUCT USE COMPLAINT |
13 |
0.0008 |
| 726 |
DYSPNOEA EXERTIONAL |
31 |
0.0008 |
| 727 |
RESPIRATORY DEPRESSION |
10 |
0.0008 |
| 728 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
58 |
0.0008 |
| 729 |
DENTAL CARIES |
9 |
0.0008 |
| 730 |
IMMUNODEFICIENCY |
12 |
0.0008 |
| 731 |
EOSINOPHILIA |
14 |
0.0008 |
| 732 |
RETCHING |
17 |
0.0008 |
| 733 |
MITRAL VALVE INCOMPETENCE |
9 |
0.0008 |
| 734 |
ABDOMINAL DISTENSION |
83 |
0.0008 |
| 735 |
DERMATITIS ALLERGIC |
10 |
0.0008 |
| 736 |
RASH ERYTHEMATOUS |
38 |
0.0008 |
| 737 |
PRURITUS GENERALISED |
17 |
0.0008 |
| 738 |
MENTAL IMPAIRMENT |
19 |
0.0008 |
| 739 |
PRESYNCOPE |
19 |
0.0008 |
| 740 |
GASTROINTESTINAL INFECTION |
7 |
0.0008 |
| 741 |
DEVELOPMENTAL DELAY |
7 |
0.0008 |
| 742 |
FACE OEDEMA |
13 |
0.0008 |
| 743 |
BRONCHOSPASM |
11 |
0.0008 |
| 744 |
RECTAL HAEMORRHAGE |
33 |
0.0008 |
| 745 |
RENAL IMPAIRMENT |
64 |
0.0008 |
| 746 |
PULMONARY ARTERIAL HYPERTENSION |
11 |
0.0008 |
| 747 |
CHOLECYSTITIS |
9 |
0.0008 |
| 748 |
HYPERLIPIDAEMIA |
9 |
0.0008 |
| 749 |
HAEMOPTYSIS |
21 |
0.0008 |
| 750 |
VIRAL INFECTION |
25 |
0.0008 |
| 751 |
SENSORY DISTURBANCE |
12 |
0.0007 |
| 752 |
LACERATION |
7 |
0.0007 |
| 753 |
DECREASED ACTIVITY |
8 |
0.0007 |
| 754 |
GLOMERULAR FILTRATION RATE DECREASED |
9 |
0.0007 |
| 755 |
CARDIOMEGALY |
9 |
0.0007 |
| 756 |
RESPIRATORY TRACT INFECTION |
19 |
0.0007 |
| 757 |
MEMORY IMPAIRMENT |
100 |
0.0007 |
| 758 |
VENTRICULAR TACHYCARDIA |
12 |
0.0007 |
| 759 |
COAGULOPATHY |
12 |
0.0007 |
| 760 |
HAEMATEMESIS |
18 |
0.0007 |
| 761 |
RASH |
309 |
0.0007 |
| 762 |
CHEST PAIN |
131 |
0.0007 |
| 763 |
BLOOD GLUCOSE ABNORMAL |
13 |
0.0007 |
| 764 |
SURGERY |
41 |
0.0007 |
| 765 |
HIATUS HERNIA |
9 |
0.0007 |
| 766 |
PULMONARY OEDEMA |
31 |
0.0007 |
| 767 |
ULCER |
11 |
0.0007 |
| 768 |
HYPERTHYROIDISM |
10 |
0.0007 |
| 769 |
CARDIAC ARREST |
57 |
0.0007 |
| 770 |
PRODUCT PRESCRIBING ISSUE |
15 |
0.0007 |
| 771 |
SWELLING |
64 |
0.0007 |
| 772 |
BONE PAIN |
40 |
0.0007 |
| 773 |
ABNORMAL BEHAVIOUR |
27 |
0.0007 |
| 774 |
DIABETES MELLITUS INADEQUATE CONTROL |
12 |
0.0007 |
| 775 |
LUNG DISORDER |
33 |
0.0007 |
| 776 |
NO ADVERSE EVENT |
121 |
0.0007 |
| 777 |
URTICARIA |
110 |
0.0007 |
| 778 |
RENAL FAILURE |
86 |
0.0006 |
| 779 |
CONJUNCTIVITIS |
12 |
0.0006 |
| 780 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
14 |
0.0006 |
| 781 |
BRADYCARDIA |
34 |
0.0006 |
| 782 |
INTERSTITIAL LUNG DISEASE |
31 |
0.0006 |
| 783 |
AGITATION |
47 |
0.0006 |
| 784 |
TREATMENT NONCOMPLIANCE |
35 |
0.0006 |
| 785 |
SKIN REACTION |
9 |
0.0006 |
| 786 |
FRACTURE |
12 |
0.0006 |
| 787 |
DYSGEUSIA |
47 |
0.0006 |
| 788 |
BLOOD URINE PRESENT |
12 |
0.0006 |
| 789 |
FUNGAL INFECTION |
21 |
0.0006 |
| 790 |
COMA |
30 |
0.0006 |
| 791 |
HYPERKALAEMIA |
22 |
0.0006 |
| 792 |
ORAL PAIN |
14 |
0.0006 |
| 793 |
LYMPHADENOPATHY |
22 |
0.0006 |
| 794 |
UNDERDOSE |
45 |
0.0006 |
| 795 |
PLATELET COUNT INCREASED |
8 |
0.0006 |
| 796 |
DYSPNOEA |
347 |
0.0006 |
| 797 |
DISTURBANCE IN ATTENTION |
33 |
0.0006 |
| 798 |
LABORATORY TEST ABNORMAL |
18 |
0.0006 |
| 799 |
DYSPEPSIA |
60 |
0.0006 |
| 800 |
CARDIOMYOPATHY |
9 |
0.0006 |
| 801 |
GASTRITIS |
16 |
0.0006 |
| 802 |
BLOOD PRESSURE ABNORMAL |
12 |
0.0006 |
| 803 |
ACCIDENTAL OVERDOSE |
22 |
0.0006 |
| 804 |
AGEUSIA |
15 |
0.0006 |
| 805 |
HYPOAESTHESIA |
90 |
0.0006 |
| 806 |
MOBILITY DECREASED |
43 |
0.0006 |
| 807 |
GAIT INABILITY |
20 |
0.0006 |
| 808 |
CONDITION AGGRAVATED |
180 |
0.0006 |
| 809 |
FLUID RETENTION |
30 |
0.0006 |
| 810 |
COUGH |
164 |
0.0006 |
| 811 |
BURNING SENSATION |
41 |
0.0006 |
| 812 |
ABDOMINAL PAIN UPPER |
120 |
0.0006 |
| 813 |
PERIPHERAL COLDNESS |
8 |
0.0006 |
| 814 |
RASH PAPULAR |
13 |
0.0006 |
| 815 |
LOCALISED INFECTION |
14 |
0.0006 |
| 816 |
THERAPEUTIC RESPONSE DECREASED |
35 |
0.0006 |
| 817 |
BACK PAIN |
134 |
0.0006 |
| 818 |
RESTLESSNESS |
21 |
0.0006 |
| 819 |
SEDATION |
15 |
0.0006 |
| 820 |
MOUTH ULCERATION |
12 |
0.0006 |
| 821 |
EAR PAIN |
11 |
0.0006 |
| 822 |
CYSTITIS |
18 |
0.0006 |
| 823 |
ORAL HERPES |
11 |
0.0006 |
| 824 |
CARDIOGENIC SHOCK |
8 |
0.0006 |
| 825 |
CHEST DISCOMFORT |
57 |
0.0006 |
| 826 |
ARRHYTHMIA |
26 |
0.0005 |
| 827 |
DEPRESSED MOOD |
29 |
0.0005 |
| 828 |
RASH MACULAR |
19 |
0.0005 |
| 829 |
CEREBROVASCULAR ACCIDENT |
92 |
0.0005 |
| 830 |
DIABETIC KETOACIDOSIS |
13 |
0.0005 |
| 831 |
ERYTHEMA |
109 |
0.0005 |
| 832 |
HYPERSENSITIVITY |
98 |
0.0005 |
| 833 |
CARDIO-RESPIRATORY ARREST |
22 |
0.0005 |
| 834 |
PAIN IN EXTREMITY |
155 |
0.0005 |
| 835 |
HALLUCINATION, VISUAL |
11 |
0.0005 |
| 836 |
DYSURIA |
19 |
0.0005 |
| 837 |
MUSCULOSKELETAL PAIN |
27 |
0.0005 |
| 838 |
CYANOSIS |
8 |
0.0005 |
| 839 |
PRODUCT DISPENSING ERROR |
11 |
0.0005 |
| 840 |
RESPIRATORY DISORDER |
15 |
0.0005 |
| 841 |
LOSS OF CONSCIOUSNESS |
64 |
0.0005 |
| 842 |
VERTIGO |
30 |
0.0005 |
| 843 |
HOT FLUSH |
37 |
0.0005 |
| 844 |
PAIN |
301 |
0.0005 |
| 845 |
ALOPECIA |
96 |
0.0005 |
| 846 |
DRUG ADMINISTRATION ERROR |
15 |
0.0005 |
| 847 |
ANAPHYLACTIC REACTION |
27 |
0.0005 |
| 848 |
PERITONITIS |
10 |
0.0005 |
| 849 |
HYPOKINESIA |
7 |
0.0005 |
| 850 |
FLUID OVERLOAD |
7 |
0.0005 |
| 851 |
SKIN DISORDER |
16 |
0.0005 |
| 852 |
ADVERSE DRUG REACTION |
43 |
0.0005 |
| 853 |
SHOCK |
11 |
0.0005 |
| 854 |
MOOD ALTERED |
13 |
0.0005 |
| 855 |
SWELLING FACE |
31 |
0.0005 |
| 856 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
8 |
0.0005 |
| 857 |
MUSCULOSKELETAL DISORDER |
9 |
0.0005 |
| 858 |
RESPIRATORY ARREST |
13 |
0.0005 |
| 859 |
HAEMATOCHEZIA |
26 |
0.0005 |
| 860 |
BLOOD PRESSURE INCREASED |
72 |
0.0005 |
| 861 |
METABOLIC ACIDOSIS |
15 |
0.0005 |
| 862 |
BLINDNESS |
19 |
0.0005 |
| 863 |
HYPOACUSIS |
20 |
0.0005 |
| 864 |
POOR QUALITY SLEEP |
10 |
0.0005 |
| 865 |
TREMOR |
77 |
0.0005 |
| 866 |
LACTIC ACIDOSIS |
15 |
0.0005 |
| 867 |
FLUSHING |
47 |
0.0005 |
| 868 |
PERIPHERAL SWELLING |
71 |
0.0005 |
| 869 |
ABDOMINAL DISCOMFORT |
77 |
0.0005 |
| 870 |
DRUG DISPENSING ERROR |
7 |
0.0005 |
| 871 |
TINNITUS |
21 |
0.0005 |
| 872 |
POLLAKIURIA |
19 |
0.0005 |
| 873 |
VISION BLURRED |
62 |
0.0005 |
| 874 |
GALLBLADDER DISORDER |
8 |
0.0004 |
| 875 |
VISUAL IMPAIRMENT |
55 |
0.0004 |
| 876 |
GASTROENTERITIS VIRAL |
8 |
0.0004 |
| 877 |
PRODUCT AVAILABILITY ISSUE |
10 |
0.0004 |
| 878 |
PARAESTHESIA |
69 |
0.0004 |
| 879 |
SKIN LESION |
12 |
0.0004 |
| 880 |
ANGIOEDEMA |
19 |
0.0004 |
| 881 |
THINKING ABNORMAL |
8 |
0.0004 |
| 882 |
RENAL DISORDER |
20 |
0.0004 |
| 883 |
DIZZINESS |
214 |
0.0004 |
| 884 |
MALAISE |
186 |
0.0004 |
| 885 |
VISUAL ACUITY REDUCED |
14 |
0.0004 |
| 886 |
TRANSIENT ISCHAEMIC ATTACK |
14 |
0.0004 |
| 887 |
BLOOD GLUCOSE INCREASED |
78 |
0.0004 |
| 888 |
HEART RATE INCREASED |
41 |
0.0004 |
| 889 |
PRODUCT DOSE OMISSION |
27 |
0.0004 |
| 890 |
GASTROOESOPHAGEAL REFLUX DISEASE |
33 |
0.0004 |
| 891 |
UNEVALUABLE EVENT |
31 |
0.0004 |
| 892 |
PSYCHOTIC DISORDER |
12 |
0.0004 |
| 893 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
73 |
0.0004 |
| 894 |
DEMENTIA |
11 |
0.0004 |
| 895 |
BLISTER |
22 |
0.0004 |
| 896 |
MUSCLE SPASMS |
71 |
0.0004 |
| 897 |
INSOMNIA |
101 |
0.0004 |
| 898 |
INJECTION SITE SWELLING |
29 |
0.0004 |
| 899 |
MEDICATION ERROR |
21 |
0.0004 |
| 900 |
NECK PAIN |
21 |
0.0004 |
| 901 |
NEPHROLITHIASIS |
17 |
0.0004 |
| 902 |
HEART RATE DECREASED |
13 |
0.0004 |
| 903 |
SKIN DISCOLOURATION |
17 |
0.0004 |
| 904 |
SKIN EXFOLIATION |
31 |
0.0004 |
| 905 |
ARTHRALGIA |
150 |
0.0004 |
| 906 |
HALLUCINATION |
27 |
0.0004 |
| 907 |
THERAPEUTIC RESPONSE UNEXPECTED |
16 |
0.0004 |
| 908 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
12 |
0.0004 |
| 909 |
CHROMATURIA |
8 |
0.0004 |
| 910 |
EXPOSURE DURING PREGNANCY |
22 |
0.0004 |
| 911 |
WEIGHT INCREASED |
79 |
0.0004 |
| 912 |
CYTOKINE RELEASE SYNDROME |
7 |
0.0003 |
| 913 |
CARDIAC FAILURE CONGESTIVE |
28 |
0.0003 |
| 914 |
PRODUCT SUBSTITUTION ISSUE |
20 |
0.0003 |
| 915 |
OROPHARYNGEAL PAIN |
32 |
0.0003 |
| 916 |
RHINORRHOEA |
22 |
0.0003 |
| 917 |
ELECTROCARDIOGRAM QT PROLONGED |
12 |
0.0003 |
| 918 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
16 |
0.0003 |
| 919 |
DRY MOUTH |
27 |
0.0003 |
| 920 |
FOETAL EXPOSURE DURING PREGNANCY |
27 |
0.0003 |
| 921 |
NASOPHARYNGITIS |
60 |
0.0003 |
| 922 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
8 |
0.0003 |
| 923 |
HIP FRACTURE |
10 |
0.0003 |
| 924 |
PRURITUS |
119 |
0.0003 |
| 925 |
ANXIETY |
88 |
0.0003 |
| 926 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
16 |
0.0003 |
| 927 |
ACUTE MYOCARDIAL INFARCTION |
9 |
0.0003 |
| 928 |
AGGRESSION |
15 |
0.0003 |
| 929 |
ABORTION SPONTANEOUS |
12 |
0.0003 |
| 930 |
CARDIAC FAILURE |
24 |
0.0003 |
| 931 |
MENTAL DISORDER |
13 |
0.0003 |
| 932 |
INTENTIONAL PRODUCT MISUSE |
26 |
0.0003 |
| 933 |
EYE SWELLING |
11 |
0.0003 |
| 934 |
DRY SKIN |
39 |
0.0003 |
| 935 |
OVERDOSE |
63 |
0.0003 |
| 936 |
DYSPHONIA |
17 |
0.0003 |
| 937 |
INFLAMMATION |
15 |
0.0003 |
| 938 |
MYALGIA |
49 |
0.0003 |
| 939 |
SWOLLEN TONGUE |
9 |
0.0003 |
| 940 |
DEPRESSION |
65 |
0.0003 |
| 941 |
BRONCHITIS |
21 |
0.0003 |
| 942 |
COVID-19 |
49 |
0.0003 |
| 943 |
ABDOMINAL PAIN LOWER |
7 |
0.0003 |
| 944 |
PREMATURE BABY |
8 |
0.0003 |
| 945 |
LIMB DISCOMFORT |
8 |
0.0003 |
| 946 |
FEMUR FRACTURE |
8 |
0.0003 |
| 947 |
FEELING ABNORMAL |
61 |
0.0003 |
| 948 |
INCORRECT DOSE ADMINISTERED |
58 |
0.0003 |
| 949 |
SINUSITIS |
26 |
0.0003 |
| 950 |
EYE PAIN |
14 |
0.0002 |
| 951 |
MATERNAL EXPOSURE DURING PREGNANCY |
22 |
0.0002 |
| 952 |
LOWER RESPIRATORY TRACT INFECTION |
11 |
0.0002 |
| 953 |
INJECTION SITE ERYTHEMA |
30 |
0.0002 |
| 954 |
SLEEP DISORDER |
17 |
0.0002 |
| 955 |
LIP SWELLING |
8 |
0.0002 |
| 956 |
BLOOD CHOLESTEROL INCREASED |
11 |
0.0002 |
| 957 |
DRUG DOSE OMISSION |
39 |
0.0002 |
| 958 |
CARDIAC DISORDER |
22 |
0.0002 |
| 959 |
INFLUENZA LIKE ILLNESS |
19 |
0.0002 |
| 960 |
PALPITATIONS |
27 |
0.0002 |
| 961 |
HYPERHIDROSIS |
29 |
0.0002 |
| 962 |
DYSKINESIA |
9 |
0.0002 |
| 963 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
8 |
0.0002 |
| 964 |
LUNG NEOPLASM MALIGNANT |
9 |
0.0002 |
| 965 |
INJECTION SITE MASS |
8 |
0.0002 |
| 966 |
EYE DISORDER |
7 |
0.0002 |
| 967 |
INFUSION RELATED REACTION |
14 |
0.0002 |
| 968 |
BLOOD GLUCOSE DECREASED |
10 |
0.0002 |
| 969 |
MYOCARDIAL INFARCTION |
35 |
0.0002 |
| 970 |
INJECTION SITE PAIN |
61 |
0.0002 |
| 971 |
ARTHROPATHY |
11 |
0.0002 |
| 972 |
ROAD TRAFFIC ACCIDENT |
8 |
0.0002 |
| 973 |
INFLUENZA |
21 |
0.0002 |
| 974 |
INJURY |
13 |
0.0002 |
| 975 |
ILLNESS |
19 |
0.0002 |
| 976 |
IRRITABILITY |
11 |
0.0002 |
| 977 |
DISCOMFORT |
10 |
0.0002 |
| 978 |
FEELING HOT |
10 |
0.0002 |
| 979 |
JOINT SWELLING |
19 |
0.0002 |
| 980 |
ACCIDENTAL EXPOSURE TO PRODUCT |
16 |
0.0002 |
| 981 |
NERVOUSNESS |
8 |
0.0002 |
| 982 |
PRODUCT DOSE OMISSION ISSUE |
42 |
0.0001 |
| 983 |
ARTHRITIS |
11 |
0.0001 |
| 984 |
PRODUCT STORAGE ERROR |
11 |
0.0001 |
| 985 |
PRODUCT QUALITY ISSUE |
17 |
0.0001 |
| 986 |
MIGRAINE |
11 |
0.0001 |
| 987 |
INJECTION SITE HAEMORRHAGE |
9 |
0.0001 |
| 988 |
MUSCULOSKELETAL STIFFNESS |
9 |
0.0001 |
| 989 |
ACNE |
7 |
0.0001 |
| 990 |
CHRONIC KIDNEY DISEASE |
7 |
0.0001 |
| 991 |
ASTHMA |
10 |
0.0001 |
| 992 |
BREAST CANCER |
8 |
0.0001 |
| 993 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
16 |
0.0001 |
| 994 |
EMOTIONAL DISTRESS |
8 |
0.0001 |
| 995 |
PSORIASIS |
8 |
0.0001 |